SELF-TEST FOR SARS-COV-2 ANTIGEN (CORONAVIRUS) - ANVISA Registration 10269360362

Access comprehensive regulatory information for SELF-TEST FOR SARS-COV-2 ANTIGEN (CORONAVIRUS) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10269360362 and manufactured by QUIBASA QUÍMICA BÁSICA LTDA. The registration is held by QUIBASA - QUIMICA BASICA LTDA with validity until May 16, 2032.

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including HANGZHOU ALLTEST BIOTECH CO. LTD, GENRUI BIOTECH INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10269360362
Registration Details
ANVISA Registration Number: 10269360362
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Registration Details

10269360362

25351096732202251

19400787000107

Company Information

Brazil
PT: BRASIL

Dates and Status

May 16, 2022

16/05/2032

09/18/2025 19:00:01